Updated Date:
11 May 2026
Product Detail:
IRINOTECAN ACCORD irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial
Shortage Status:
Current
AUST R:
209857
Availability:
Limited Availability
Active Ingredient:
irinotecan hydrochloride trihydrate
Reason:
Manufacturing
Dosage Form:
Injection,concentrated
Supply Impact Dates
From 08 May 2026
To 15 Jun 2026
Management Action:
An alternative brand is available.